Form 4 for ANTX AN2 Therapeutics, Inc.
Accepted 2024-11-20 00:00:00 ET · period of report 2024-11-18 · accession 0000950170-24-129248 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-20 | 2024-11-18+ | ANTX | Zakrzewski Joseph S | Dir | P - Purchase | $1.00 | +25.0K | 118.2K | +27% | +$25.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-19 | P | A | 5,000 | $1.01 | 123,199 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-18 | P | A | 20,000 | $1.00 | 118,199 | D | — | — |